Clinical Trial Update: Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a single low dose tafenoquine to reduce transmission of Plasmodium falciparum malaria in Mali has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Tafenoquine (tafenoquine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria, Falciparum | Phase 2 | Status: COMPLETED